AVTX
Price
$4.75
Change
-$0.21 (-4.23%)
Updated
Jul 7 closing price
Capitalization
51.43M
FGEN
Price
$5.37
Change
-$0.24 (-4.28%)
Updated
Jul 7 closing price
Capitalization
21.7M
34 days until earnings call
Interact to see
Advertisement

AVTX vs FGEN

Header iconAVTX vs FGEN Comparison
Open Charts AVTX vs FGENBanner chart's image
Avalo Therapeutics
Price$4.75
Change-$0.21 (-4.23%)
Volume$30K
Capitalization51.43M
FibroGen
Price$5.37
Change-$0.24 (-4.28%)
Volume$37.3K
Capitalization21.7M
AVTX vs FGEN Comparison Chart in %
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. FGEN commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Buy and FGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 08, 2025
Stock price -- (AVTX: $4.75 vs. FGEN: $5.37)
Brand notoriety: AVTX and FGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 33% vs. FGEN: 87%
Market capitalization -- AVTX: $51.43M vs. FGEN: $21.7M
AVTX [@Biotechnology] is valued at $51.43M. FGEN’s [@Biotechnology] market capitalization is $21.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 1 FA rating(s) are green whileFGEN’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 1 green, 4 red.
  • FGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, AVTX is a better buy in the long-term than FGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 5 TA indicator(s) are bullish while FGEN’s TA Score has 4 bullish TA indicator(s).

  • AVTX’s TA Score: 5 bullish, 3 bearish.
  • FGEN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AVTX is a better buy in the short-term than FGEN.

Price Growth

AVTX (@Biotechnology) experienced а -4.81% price change this week, while FGEN (@Biotechnology) price change was +1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.42%. For the same industry, the average monthly price growth was +12.24%, and the average quarterly price growth was -0.68%.

Reported Earning Dates

AVTX is expected to report earnings on May 12, 2025.

FGEN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+3.42% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTX($51.4M) has a higher market cap than FGEN($21.7M). AVTX YTD gains are higher at: -36.070 vs. FGEN (-59.433). AVTX has higher annual earnings (EBITDA): -50.14M vs. FGEN (-110.48M). AVTX has more cash in the bank: 125M vs. FGEN (1.73M). AVTX has less debt than FGEN: AVTX (801K) vs FGEN (73.4M). FGEN has higher revenues than AVTX: FGEN (7M) vs AVTX (441K).
AVTXFGENAVTX / FGEN
Capitalization51.4M21.7M237%
EBITDA-50.14M-110.48M45%
Gain YTD-36.070-59.43361%
P/E Ratio0.04N/A-
Revenue441K7M6%
Total Cash125M1.73M7,225%
Total Debt801K73.4M1%
FUNDAMENTALS RATINGS
AVTX vs FGEN: Fundamental Ratings
AVTX
FGEN
OUTLOOK RATING
1..100
1253
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5100
PRICE GROWTH RATING
1..100
6493
P/E GROWTH RATING
1..100
9955
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVTX's Valuation (84) in the Pharmaceuticals Other industry is in the same range as FGEN (93) in the Biotechnology industry. This means that AVTX’s stock grew similarly to FGEN’s over the last 12 months.

AVTX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as FGEN (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to FGEN’s over the last 12 months.

AVTX's SMR Rating (5) in the Pharmaceuticals Other industry is significantly better than the same rating for FGEN (100) in the Biotechnology industry. This means that AVTX’s stock grew significantly faster than FGEN’s over the last 12 months.

AVTX's Price Growth Rating (64) in the Pharmaceuticals Other industry is in the same range as FGEN (93) in the Biotechnology industry. This means that AVTX’s stock grew similarly to FGEN’s over the last 12 months.

FGEN's P/E Growth Rating (55) in the Biotechnology industry is somewhat better than the same rating for AVTX (99) in the Pharmaceuticals Other industry. This means that FGEN’s stock grew somewhat faster than AVTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXFGEN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 14 days ago
86%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
87%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BPRN32.26-0.40
-1.21%
Princeton Bancorp
BRSP5.12-0.15
-2.85%
BrightSpire Capital
ABEV2.39-0.08
-3.24%
Ambev SA
CTRM2.18-0.09
-3.96%
Castor Maritime
GT10.89-0.45
-3.97%
Goodyear Tire & Rubber Company (The)

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
-4.23%
FGEN - AVTX
57%
Loosely correlated
-4.28%
MEOBF - AVTX
46%
Loosely correlated
N/A
MRSN - AVTX
37%
Loosely correlated
+5.11%
PGEN - AVTX
34%
Loosely correlated
-1.85%
BDRX - AVTX
32%
Poorly correlated
+0.80%
More